The global myomectomy market size is anticipated to reach USD 1.1 billion by 2027, expanding at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from health issues such as uterine fibroids, endometriosis, and chronic pelvic pain are factors driving the market.
Myomectomy
is the surgical method to eradicate fibroids without affecting the healthy
tissue of the uterus. Fibroids majorly develop in 50.0% of women, which have
led to increased demand for the procedure and it preserves the uterus, unlike
hysterectomy. Therefore, it is considered the standard of care for eliminating
fibroids. This is anticipated to boost market growth over the forecast period.
Moreover,
increased patient preference for less invasive treatments is expected to boost
the market growth. Nowadays, minimally invasive treatment options for the
procedure include laparoscopic or robotic, and hysteroscopic myomectomy. All
these techniques are minimally invasive and eliminate the need for general
anesthesia. These procedures also cause less discomfort and post-operative
pain.
Furthermore,
the incorporation of new technologies and the introduction of new products by
market players are expected to boost market growth during the forecast period.
For instance, Intuitive Surgical has launched the Single Port Platform”-da
Vinci SP Surgical System. It enables doctors with robotic-assisted technology
intended for deep and narrow access to tissue during various urological
procedures.
Full Research Report On Myomectomy Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/myomectomy-market
Myomectomy Market
Report Highlights
- Based on type, the abdominal
myomectomy segment dominated the market with a share of 39.4% in 2019, as
this procedure is the established permanent solution for large fibroids
growing in the uterine wall
- On the basis of product,
others segment dominated the overall market with a share of 36.64% in
2019. Since, this segment offers benefits such as same-day procedure, less
invasive treatment, and faster recovery as compared to other products
- North America dominated the
market with a major share of 53.05% in 2019 owing to the increasing uterus
related illnesses in the region and availability of the latest treatment
procedures.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/myomectomy-market/request/rs1
Myomectomy Market
Segmentation
Grand View Research has segmented
the global myomectomy market on the basis of type, product, and region:
Myomectomy Type
Outlook (Revenue, USD Million, 2016 - 2027)
- Abdominal Myomectomy
- Hysteroscopic Myomectomy
- Laparoscopic Myomectomy
Myomectomy Product
Outlook (Revenue, USD Million, 2016 - 2027)
- Laparoscopic Power
Morcellators
- Harmonic Scalpel
- Laparoscopic Sealer
- Others
Myomectomy Regional
Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- The Middle East &
Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
List of Key Players
of Myomectomy Market
- Medtronic
- Stryker Corporation
- CONMED Corporation
- INSIGHTEC
- CooperSurgical Inc.
- Hologic, Inc.
- Intuitive Surgical
- Karl Storz
- B. Braun Melsungen AG
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company, registered
in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment